Passions

Health, spending time with family, crossfit

Experience

Hengrui Pharma and Braveheart Bio Enter Into Exclusive License Agreement

September 5, 2025

Cooley advised Hengrui Pharma, a global pharmaceutical company, on its exclusive license agreement with Braveheart Bio for HRS-1893, a small-molecule inhibitor of cardiac myosin independently developed by Hengrui Pharma with best-in-class potential.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Freddy Yip
Associate, Hong Kong
Steve Przesmicki
Partner, San Diego
Navya Dasari
Associate, New York
Max Levinbook
Associate, San Diego
Jeffrey J. Tolin
Partner, New York
Amanda Pacheco
Associate, Palo Alto
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Zhijing Yu
Associate, Singapore
Christopher Kimball
Partner, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Rachel Thorn
Of counsel, New York
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries

Enlaza Therapeutics Announces Strategic Collaboration With Vertex Pharmaceuticals

September 2, 2025

Cooley advised Enlaza Therapeutics, the first covalent biologics platform company, on its multi-target drug discovery collaboration with Vertex Pharmaceuticals, to utilize Enlaza’s proprietary War-Lock technology platform to develop small format drug conjugates and T-cell engagers for certain autoimmune diseases and improved conditioning in sickle cell disease and beta thalassemia.

Read more

Related contacts

Charity Williams
Partner, San Diego
Emily Mason
Special Counsel, Santa Monica
Ken Rollins
Partner in Charge – San Diego, San Diego
Dylan Kornbluth
Associate, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Rachel Thorn
Of counsel, New York
Navya Dasari
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Matthew S. Scarano
Associate, San Diego
Max Levinbook
Associate, San Diego

Related Practices & Industries

Malachite Acquired by Circle Internet Group

August 12, 2025

Cooley advised Circle Internet Group (NYSE: CRCL), a global financial technology firm, on its acquisition of Malachite, a high-performance consensus engine from Informal Systems, to support the launch of Arc, a new open Layer-1 blockchain network purpose-built for stablecoin finance, which is expected to debut in testnet later this year.

Read more

Related contacts

Adam Shaun Bloom
Partner, Palo Alto
Patrick Reed
Associate, Palo Alto
Ross Eberly
Partner, Santa Monica
Steve Flores
Partner, Chicago
Charles Haley
Partner, Palo Alto
Jean Park
Partner, New York
Milson Yu
Partner, Palo Alto
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Chris Chynoweth
Special Counsel, New York
Jeff Goldman
Special Counsel, Palo Alto
Ryan Bowers
Associate, Washington, DC
Joshua Elefant
Associate, Palo Alto
Eileen Leman
Associate, Los Angeles
Amanda Pacheco
Associate, Palo Alto
Patricia Myers
Paralegal Specialist, Colorado
Joanna Leung
Associate, Palo Alto

Related Practices & Industries

Shoulder Innovations Announces $75 Million IPO

July 31, 2025

Cooley advised the underwriters of Shoulder Innovations, a medical technology company exclusively focused on transforming the shoulder surgical care market, in connection with Shoulder Innovations’ $75 million initial public offering (IPO).

Read more

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Scott Weston
Partner, Boston
Kassity L. Mai
Special Counsel, Reston
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Valerie Sapozhnikova
Associate, Los Angeles
Alex Hammer
Associate, San Francisco
Allison Kutner
Associate, New York
Sunny J. Levine
Associate, Colorado
Ryan Lewis
Associate, Colorado
Sarah Miller
Associate, New York
Marjorie O'Neill
Associate, San Francisco
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Blue Owl Capital Extends up to $500 Million in Senior Secured Credit to Madrigal Pharmaceuticals

July 21, 2025

Cooley advised Blue Owl (NYSE: OWL), a leading asset manager redefining alternatives, on an up to $500 million term loan facility for Madrigal Pharmaceuticals (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis.

Read more

Related contacts

Michael Tollini
Partner, Washington, DC
Addison Pierce
Partner, Chicago
Dr. Jon Cousin
Partner, Washington, DC
Geoffrey Spolyar
Partner, Boston
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Steve Flores
Partner, Chicago
Michael Neumeister
Partner, Los Angeles
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Wyatt Kernell
Associate, Colorado
Dr. Asako Kubota
Associate, Washington, DC
Allison Kutner
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Charles A. Watkins II
Associate, Santa Monica
Jeffery Wyzykowski
Patent Agent, Washington, DC
Margie Murphy
Paralegal Specialist, New York

Related Practices & Industries

View more

Admissions and credentials

California

Memberships and affiliations

American Bar Association - Section of Taxation

Hispanic National Bar Association (HNBA)

State Bar of California, Taxation Section